5938 — Lixil Balance Sheet
0.000.00%
- ¥462bn
- ¥992bn
- ¥2tn
- 39
- 67
- 35
- 44
Annual balance sheet for Lixil, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Yuho | Yuho | Yuho | Yuho | Tanshin |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 121,730 | 118,246 | 125,541 | 135,887 | 130,703 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 311,795 | 300,740 | 314,838 | 322,977 | 303,466 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 637,773 | 714,607 | 744,533 | 730,778 | 701,241 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 465,086 | 427,324 | 440,066 | 438,675 | 429,082 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 1,741,814 | 1,782,882 | 1,853,534 | 1,886,595 | 1,830,804 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 586,928 | 603,001 | 652,202 | 594,592 | 571,783 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 1,189,543 | 1,170,497 | 1,228,101 | 1,244,084 | 1,212,918 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 552,271 | 612,385 | 625,433 | 642,511 | 617,886 |
Total Liabilities & Shareholders' Equity | 1,741,814 | 1,782,882 | 1,853,534 | 1,886,595 | 1,830,804 |
Total Common Shares Outstanding |